Position in UTHR
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$7,323,301
-$3,614,738 QoQ
Shares Held
12,350
-60.2% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
1.20%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Derivatives in UTHR
reported options exposure · as of Mar 31, 2021CallValue
$66,907
CallShares
400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Atika Capital Management LLC holds $19,289,967 across 3 Drug Manufacturers - Specialty & Generic names.
All Filings in UTHR
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,323,301 | 12,350 | Shares | Defined | 2026-05-14 | |
| 2024-12-31 | $10,938,039 | 31,000 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $9,854,623 | 27,500 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $9,237,949 | 29,000 | Shares | Defined | 2024-08-13 | |
| 2022-12-31 | $15,131,431 | 54,412 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $11,097,138 | 53,000 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $13,902,759 | 59,000 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $8,791,088 | 49,000 | Shares | Defined | 2022-05-13 | |
| 2021-03-31 | $66,907 | 400 | Call | Defined | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||